What happened
Vivozon Pharmaceutical updated the terms of a new share issuance to raise US$22.6M, about 17.6% of its market value.
For context, this raise equals about 17.6% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$22.6M |
| vs. market value | 17.6% |
| Filed | 2026-02-19, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260219002337 → open original filing |
Source: DART. Information only, not investment advice.